Schroder Investment Management Group Myovant Sciences Ltd. Transaction History

Schroder Investment Management Group

  • $94.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$11.38 - $16.4 $908,738 - $1.31 Million
-79,854 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$14.31 - $23.87 $1.14 Million - $1.91 Million
79,854 New
79,854 $1.24 Million
Q3 2021

Nov 12, 2021
SELL
$18.94 - $26.99 $4.67 Million - $6.65 Million
-246,528 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$17.07 - $24.56 $4.21 Million - $6.05 Million
246,528 New
246,528 $5.61 Million

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email